⌘K

Home/Filings/4/0001178913-22-000091

4//SEC Filing

Mayron Ron 4

Accession 0001178913-22-000091

CIK 0001638097other

View on SEC.gov Company Profile

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 4:09 PM ET

Size

7.6 KB

Accession

0001178913-22-000091

Insider Transaction Report

Form 4

Period: 2022-01-01

Entera Bio Ltd.ENTX

Director

Transactions

Award
Stock Option (right to buy)
2022-01-01+107,557→ 107,557 total
Exercise: $2.81Exp: 2032-01-01→ Ordinary Shares, par value NIS 0.0000769 per share (107,557 underlying)
Award
Stock Option (right to buy)
2022-01-01+35,852→ 35,852 total
Exercise: $2.81Exp: 2032-01-01→ Ordinary Shares, par value NIS 0.0000769 per share (35,852 underlying)

Footnotes (2)

[F1]The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022.
[F2]The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022.

Documents

1 file

4
zk2227045.xmlPrimary

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1

filerCIK 0001722033

Filing Metadata

Form type: 4
Filed: Jan 10, 7:00 PM ET
Accepted: Jan 11, 4:09 PM ET
Size: 7.6 KB

View on SEC.gov